Table 1 Patient characteristics by employment status and educational level
Total (%) | Distribution (%) | |||||
|---|---|---|---|---|---|---|
| Â | Total cohort | Employed | Non-employed | Post-secondary school | Upper secondary school | Compulsory school |
|  | N = 3874 | N = 3836 (with data on employment) | N = 3767 (with data on education) | |||
| Â | Â | 2046 (53.3) | 1790 (46.7) | 719 (19.1) | 1818 (48.3) | 1230 (32.7) |
Age (years) | ||||||
 Median | 57 | 56 | 58 | 56 | 57 | 58 |
 25th percentile | 50 | 48 | 52 | 47 | 48 | 52 |
 75th percentile | 61 | 60 | 62 | 61 | 61 | 62 |
Gender | ||||||
 Women | 1239 (32.0) | 585 (28.6) | 648 (36.2) | 263 (36.6) | 583 (32.1) | 366 (29.8) |
 Men | 2635 (68.0) | 1461 (71.4) | 1142 (63.8) | 456 (63.4) | 1235 (67.9) | 864 (70.2) |
Income (€)a | ||||||
 Median | 13,673 | 17,490 | 11,240 | 17,279 | 13,808 | 12,356 |
 25th percentile | 10,308 | 12,769 | 8817 | 11,548 | 10,587 | 9760 |
 75th percentile | 19,962 | 23,466 | 14,000 | 24,365 | 19,548 | 18,346 |
Follow -up time (days) | ||||||
 Range | 1–1643 | 1–1641 | 1–1643 | 1–1635 | 1–1639 | 1–1643 |
 Median | 737 | 777 | 688 | 738 | 726 | 746 |
 25th percentile | 322 | 372 | 281 | 307 | 333 | 312 |
 75th percentile | 1179 | 1207 | 1151 | 1135 | 1178 | 1192 |
Comorbidity | ||||||
 Hypertension | 1088 (28.4) | 576 (28.2) | 512 (28.6) | 200 (27.8) | 521 (28.7) | 339 (27.6) |
 Diabetes mellitus | 585 (15.1) | 198 (9.7) | 377 (21.1) | 97 (13.5) | 267 (14.7) | 196 (15.9) |
 Angina pectoris | 213 (5.5) | 93 (4.5) | 117 (6.5) | 34 (4.7) | 103 (5.7) | 68 (5.5) |
 Myocardial infarction | 424 (10.9) | 193 (9.4) | 225 (12.6) | 62 (8.6) | 206 (11.3) | 143 (11.6) |
 Atrial fibrillation/flutter | 958 (24.7) | 517 (25.3) | 429 (24.0) | 176 (24.5) | 434 (23.9) | 323 (26.3) |
 Pacemaker | 115 (3.0) | 56 (2.7) | 58 (3.2) | 28 (3.9) | 49 (2.7) | 34 (2.8) |
 Stroke | 120 (3.1) | 36 (1.8) | 84 (4.7) | 17 (2.4) | 59 (3.2) | 42 (3.4) |
 Renal dysfunction | 208 (5.4) | 69 (3.4) | 137 (7.7) | 29 (4.0) | 107 (5.9) | 67 (5.4) |
 Vascular disease | 65 (1.7) | 25 (1.2) | 40 (2.2) | 8 (1.1) | 31 (1.7) | 25 (2.0) |
 Rheumatic disease | 65 (1.7) | 20 (1.0) | 45 (2.5) | 10 (1.4) | 28 (1.5) | 27 (2.2) |
 Lung disease | 581 (15.0) | 198 (9.7) | 378 (21.1) | 71 (9.9) | 283 (15.6) | 207 (16.8) |
 Liver disease | 92 (2.4) | 33 (1.6) | 59 (3.3) | 13 (1.8) | 45 (2.5) | 32 (2.6) |
 CABG | 193 (5.0) | 80 (3.9) | 111 (6.2) | 31 (4.3) | 94 (5.2) | 62 (5.0) |
 Anaemia | 176 (4.5) | 44 (2.2) | 131 (7.3) | 23 (3.2) | 91 (5.0) | 58 (4.7) |
 Cancer | 118 (3.0) | 64 (3.1) | 53 (3.0) | 22 (3.1) | 50 (2.8) | 44 (3.6) |
 Dementia | 8 (0.2) | 3 (0.1) | 5 (0.3) | 1 (0.1) | 5 (0.3) | 2 (0.2) |
 Psychiatric disease | 359 (9.3) | 97 (4.7) | 257 (14.4) | 43 (6.0) | 171 (9.4) | 137 (11.1) |
RASb < 30 days (among 30-day survivors, N = 3731) | 2802 (75.1) | 1627 (82.2) | 1157 (67.5) | 524 (75.0) | 1327 (76.0) | 886 (75.0) |